IRIS
MARZIONI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.489
EU - Europa 3.787
AS - Asia 2.607
SA - Sud America 811
AF - Africa 138
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 3
Totale 15.844
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.398
SG - Singapore 975
BR - Brasile 696
UA - Ucraina 650
CN - Cina 586
IT - Italia 542
RU - Federazione Russa 464
IE - Irlanda 443
SE - Svezia 397
DE - Germania 394
HK - Hong Kong 319
VN - Vietnam 224
DK - Danimarca 223
GB - Regno Unito 183
TR - Turchia 179
FI - Finlandia 176
FR - Francia 132
KR - Corea 114
CI - Costa d'Avorio 58
IN - India 55
AR - Argentina 50
CA - Canada 50
MA - Marocco 43
NL - Olanda 41
PL - Polonia 39
JP - Giappone 31
ID - Indonesia 30
MX - Messico 30
ES - Italia 29
BD - Bangladesh 27
BE - Belgio 23
ZA - Sudafrica 23
AT - Austria 19
EC - Ecuador 18
IQ - Iraq 16
CO - Colombia 15
PY - Paraguay 13
UZ - Uzbekistan 10
PK - Pakistan 8
LT - Lituania 7
RO - Romania 7
CL - Cile 6
EU - Europa 6
EG - Egitto 5
RS - Serbia 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
IL - Israele 4
IR - Iran 4
TN - Tunisia 4
AZ - Azerbaigian 3
BH - Bahrain 3
HN - Honduras 3
JO - Giordania 3
PE - Perù 3
VE - Venezuela 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CU - Cuba 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GF - Guiana Francese 1
GT - Guatemala 1
IS - Islanda 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
PW - Palau 1
Totale 15.844
Salva come PNG Salva come JPEG
Città #
Ashburn 812
Chandler 763
Jacksonville 696
Dallas 642
Fairfield 592
Singapore 544
Dublin 442
Des Moines 427
Boardman 390
Hong Kong 317
Woodbridge 277
Wilmington 275
Houston 259
New York 246
Seattle 222
Cambridge 207
Centro 202
Los Angeles 164
Lawrence 161
Princeton 160
San Mateo 148
The Dalles 143
Ann Arbor 124
Beijing 112
Moscow 90
Hefei 83
San Diego 82
Munich 77
Ho Chi Minh City 69
Chicago 62
Buffalo 61
Abidjan 58
Washington 57
São Paulo 52
London 47
Hanoi 46
Turku 41
Guangzhou 36
Warsaw 32
Ancona 31
Turin 30
Shanghai 29
Brooklyn 28
Helsinki 26
Rio de Janeiro 26
Santa Clara 26
Nuremberg 25
Wuhan 23
Tokyo 21
Denver 20
Chennai 18
Orem 18
Salt Lake City 18
Brussels 17
Johannesburg 17
Norwalk 17
Pune 17
Marche 16
Montreal 16
Columbus 15
Da Nang 15
Haiphong 14
Stockholm 14
Wuxi 14
Atlanta 13
Council Bluffs 13
Poplar 13
Brasília 12
Jiaxing 12
Mexico City 12
Salamanca 12
Salvador 12
Porto Alegre 11
Tampa 11
Elk Grove Village 10
Toronto 10
Torre Annunziata 10
Ankara 9
Belo Horizonte 9
Curitiba 9
Kilburn 9
Manchester 9
Ottawa 9
Vienna 9
Fayetteville 8
Izmir 8
Milan 8
Perugia 8
Rome 8
San Francisco 8
Sterling 8
Baghdad 7
Boston 7
Campinas 7
Falls Church 7
Frankfurt am Main 7
Phoenix 7
Ribeirão Preto 7
Secaucus 7
Tashkent 7
Totale 10.062
Salva come PNG Salva come JPEG
Nome #
Use of nailfold capillaroscopy for the early diagnosis of systemic sclerosis in patients with primary biliary cholangitis 185
Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: a large retrospective cross-sectional study. 177
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 172
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury 161
H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. 147
HDL cholesterol protects from liver injury in mice with intestinal specific LXRα activation 147
Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury. 145
Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes 145
Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes 134
Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis 134
Aging and the Biological Response to Liver Injury 131
Exendin-4 restores ppar-alpha and ppar-gamma activity in nash and reduces insulin resistance, pro-inflammatory mediators and total fatty acid content 130
Shear wave elastography and transient elastography in HCV patients after direct-acting antivirals 128
Descriptive epidemiology of cholangiocarcinoma in Italy. 127
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. 127
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) 126
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 125
cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway 124
Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution 123
Hepatitis E in a region of Italy: An emerging autochthonous infection? 123
Aging-Related Molecular Pathways in Chronic Cholestatic Conditions 123
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice 122
Cholangiocarcinoma development: the resurgence of bile acids 122
Administration of r-VEGF-A prevents hepatic artery ligation induced bile duct damage in bile duct ligated rats. 121
Clinical implications of novel aspects of biliary pathophysiology. 121
Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. 121
Gut-Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology 120
Increased local dopamine secretion has growth promoting effects in cholangiocarcinoma. 119
Bullous pemphigoid of Lever and celiac disease: a coincidental occurrence or an unusual association? 119
Leptin enhances cholangiocarcinoma cell growth. 119
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 119
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma 119
Bile acid depletion and repletion regulate cholangiocyte proliferation and secretion in bile duct ligated rats through a phosphatidylinositol 3-kinase-dependent pathway. 118
An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma. 117
Pancreatic Duodenal Homeobox-1 de novo expression drives cholangiocyte neuroendocrine-like transdifferentiation. 113
Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies 113
CAMP STIMULATES THE SECRETORY AND PROLIFERATIVE CAPACITY OF THE RAT BILIARY EPITHELIUM THROUGH CHANGES IN THE PKA/SRC/MEK/ERK1/2 PATHWAY 112
Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. 112
Functional and Structural Features of Cholangiocytes in Health and Disease 112
Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. 111
PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: Perspectives in the diagnosis of pancreatic cancer 111
Current targets for Primary Sclerosing cholangitis 110
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome 110
Exendin-4, a glucagon-like protein-1 receptor agonist, reduces proinflammatory conditions, and increases lipid oxidation and insulin sensitivity in hepatocytes from nonalcoholic steatohepatitis rats 109
Selective inhibition of ion transport mechanisms regulating intracellular pH reduces proliferation and induces apoptosis in cholangiocarcinoma cells. 109
Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models 109
Exendin-4, a Glucagon-Like Peptide 1 receptor agonist, protects cholangiocytes from apoptosis 108
Gastrin reverses established cholangiocyte proliferation and enhanced secretin-stimulated ductal secretion of BDL rats by activation of apoptosis through increased expression of Ca2+- dependent PKC isoforms. 108
Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology 107
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 107
Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic Acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts 106
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease. 105
Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cells 103
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 103
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 103
Serum micrornas as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 102
Bile Acids in Polycystic Liver Diseases: Triggers of Disease Progression and Potential Solution for Treatment 102
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 101
Epidemiology of primary biliary cholangitis in Italy: Evidence from a real-world database 98
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. 97
Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies 97
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis 97
Cariporide a selective Na+ /H+ exchange inhibitor, reduces PDGF-induced proliferation and oxidative stress product formation in rat hepatic stellate cells (HSC). 97
Current and novel therapeutic opportunities for systemic therapy in biliary cancer 97
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 96
Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret 96
Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats 95
Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin 95
Glucagon-like Peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis 95
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 95
Autocrine Regulation of Biliary Pathology by Activated Cholangiocytes. 94
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation 94
Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis 93
Functional heterogeneity of the intrahepatic biliary tree 92
Role of apoptosis in development of primary biliary cirrhosis 92
Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat. 92
Selective Na+/H+ inhibition by cariporide reduces liver fibrosis in the rat 91
Taurocholic acid feeding prevents tumor necrosis factor-alpha-induced damage of cholangiocytes by a PI3K-mediated pathway. 91
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 89
The secretin/secretin receptor axis modulates liver fibrosis through changes in transforming growth factor-β1 biliary secretion in mice 89
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 89
PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitis 87
Primary Biliary Cholangitis: advances in management and treatment of the disease 87
Development and functional characterization of extrahepatic cholangiocyte lines from normal rats 87
Role of cholangiocytes in primary biliary cirrhosis 86
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis 86
Cytoprotective effects of taurocholic acid feeding on the biliary tree after adrenergic denervation of the liver 85
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 85
Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases 85
Cholangiocarcinoma 2020: the next horizon in mechanisms and management 85
NUOVA METODICA DIAGNOSTICA PER LE NEOPLASIE DEL PANCREAS 84
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 84
Heterogeneity of the Intrahepatic Biliary Epithelium 84
Liver carcinogenesis: Rodent models of hepatocarcinoma and cholangiocarcinoma 83
The significance of genetics for cholangiocarcinoma development 82
Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice 82
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 82
Small Mouse cholangiocytes proliferate in response to H1 Histamine receptor stimulation by activation of the IP3/CAMK I/CREB pathway. 81
Involvement of autophagy in ageing and chronic cholestatic diseases 81
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: A multicenter study of 664 patients and 1992 healthy controls 80
Totale 10.834
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.195
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.195
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.332 0 0 0 0 0 141 183 188 205 242 226 147
2021/20221.351 71 341 19 36 14 68 79 83 67 98 219 256
2022/20232.495 212 202 140 188 154 616 4 160 600 13 159 47
2023/20241.519 246 33 118 302 241 326 16 29 11 27 10 160
2024/20252.771 317 277 103 45 82 115 159 96 702 206 282 387
2025/20263.707 501 450 695 1.099 842 120 0 0 0 0 0 0
Totale 16.295